The European Parliament’s Committee on the Environment, Public Health and Food Safety (ENVI) discussed, on Wednesday 26 May, the draft report by the MEP Dolors Montserrat (EPP, Spain) on the new Pharmaceutical Strategy for Europe (see EUROPE B12609A10).
The different political groups welcomed the draft report - detailed in our columns when it was published at the end of April(see EUROPE B12710A9) - and considered it a good basis for further work.
However, several groups insisted - and...